MedPath

Identification of a Risk Profile Associated with Failure of the Cryoballoon Ablation of Atrial Fibrillation; a Multicenter Explorative Registry.

Recruiting
Conditions
Atrial Fibrillation
10007521
Registration Number
NL-OMON46840
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
600
Inclusion Criteria

1. Patients who have agreed to undergo the cryoballoon ablation procedure for atrial fibrillation.
2. Age >18 years.
3. Written informed consent.

Exclusion Criteria

1. Patients who had a prior ablation treatment because of atrial fibrillation.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary objective is to assess a risk profile, including circulating<br /><br>biomarkers and genetic background, associated with failure of the cryoballoon<br /><br>AF ablation, i.e. any (a)symptomatic AF/AFL/AT >30 sec without anti-arrhythmic<br /><br>drugs determined within 1 year of follow-up by ECG recording and 1-day Holter<br /><br>monitoring.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes concern the identification of a risk profile associated with<br /><br>(long term) failure or success of the procedure; the number of patients<br /><br>requiring repeat baltaion following cryoballoon AF ablation; the<br /><br>electrophysiological findings during the (redo) procedure; procedural<br /><br>predictors of succes of the cryoballoon AF ablation; the incidence and type of<br /><br>supraventricular tachyarrhythmia*s following the procedure; the occurence of<br /><br>major cardiac and cardiovascular events; safety of the cryoballoon AF ablation;<br /><br>changes in left atrial size and function following ablation; the degree of<br /><br>epicardial adipose tissue; the use of anti-arrhythmic drugs; the frequency of<br /><br>repeated ablations; quality of life and physical activity.</p><br>
© Copyright 2025. All Rights Reserved by MedPath